Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection
- 31 October 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (4) , 933-937
- https://doi.org/10.1016/0002-8703(92)90975-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The preexcitation syndromesPublished by Elsevier ,2004
- Effects of postural changes versus exercise on the electrophysiologic parameters of the accessory pathwayThe American Journal of Cardiology, 1991
- Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainideJournal of the American College of Cardiology, 1990
- Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden deathThe American Journal of Cardiology, 1989
- Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1989
- Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardiaThe American Journal of Cardiology, 1988
- Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndromeJournal of the American College of Cardiology, 1987
- Long Term Use of Flecainide in Patients with Supraventricular TachycardiaDrugs, 1985
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Determination of Flecainide in Human Plasma by High Performance Liquid Chromatography with Fluorescence DetectionJournal of Liquid Chromatography, 1984